Iran Faces Severe Shortage of Medicines Amid US Sanctions

News Desk
TEHRAN: Iran is grappling with a critical shortage of medicines, exacerbated by ongoing US sanctions, leading to the unavailability of many essential drugs and skyrocketing prices for those that remain accessible.
The Iranian health sector, which produces approximately 80% of its medicines domestically, is heavily reliant on imported raw materials.
Reports indicate that the sanctions have disrupted supply chains, causing widespread panic among citizens who are struggling to find necessary medications.
This shortage poses significant risks to public health, as many patients with chronic illnesses are unable to access their required treatments.
The economic strain is further compounded by rising inflation, which has made even available medications unaffordable for a large segment of the population.
Authorities are expected to convene in the coming weeks to discuss potential solutions, including negotiations for easing sanctions or increasing domestic production capabilities.
The situation remains dire, and immediate action is crucial to alleviate the suffering of millions of Iranians.